GentiBio
- Biotech or pharma, therapeutic R&D
GentiBio, Inc. is developing engineered Tregs to (re)establish immune tolerance and provide tissue specific immune suppression to treat patients living with autoimmune, alloimmune, inflammatory and allergic diseases.